
PURR.AI is a biotechnology company focused on combating age-related neurological diseases through AI-powered drug discovery. Their platform aims to map key targets with precision and offers an end-to-end, modular system called AGELESS that can be tailored to specific needs. They also provide AGELESS.DB, a database of extracted knowledge for AI applications, and AGELESS.MAP, which utilizes proprietary algorithms for transparent and efficient AI solutions in drug discovery. The company, founded by Irina Moreira (PhD), José Macieira (MSc, BEng), and Nícia Rosário-Ferreira (PhD), leverages expertise in various scientific and business fields to accelerate treatment development and improve healthcare.

PURR.AI is a biotechnology company focused on combating age-related neurological diseases through AI-powered drug discovery. Their platform aims to map key targets with precision and offers an end-to-end, modular system called AGELESS that can be tailored to specific needs. They also provide AGELESS.DB, a database of extracted knowledge for AI applications, and AGELESS.MAP, which utilizes proprietary algorithms for transparent and efficient AI solutions in drug discovery. The company, founded by Irina Moreira (PhD), José Macieira (MSc, BEng), and Nícia Rosário-Ferreira (PhD), leverages expertise in various scientific and business fields to accelerate treatment development and improve healthcare.